<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the clinical manifestations, treatment and prognosis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The cases of 72 patients with defined APS admitted from Jan 1990 to Jan 2006 were analyzed retrospectively </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: 21 patients with primary APS and 51 patients with secondary APS were studied </plain></SENT>
<SENT sid="3" pm="."><plain>Vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> was present in 43 (59.7%) of the 72 patients in this study </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001627'>Cardiac abnormalities</z:hpo> could be observed in 48 patients (66.6%) </plain></SENT>
<SENT sid="5" pm="."><plain>Lesions most frequently involved left-sided valves, mitral (35.4%) more commonly affected than aortic (16.7%) </plain></SENT>
<SENT sid="6" pm="."><plain>Cardiac involvement was significantly related to <z:mp ids='MP_0005048'>thrombosis</z:mp> (P = 0.007) and <z:hpo ids='HP_0003645'>prolonged activated partial thromboplastin time</z:hpo> (APTT) (P = 0.026) </plain></SENT>
<SENT sid="7" pm="."><plain>Valvular involvement was significantly related to brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> (P = 0.008) and <z:mp ids='MP_0005048'>thrombosis</z:mp> (P = 0.029) </plain></SENT>
<SENT sid="8" pm="."><plain>20 APS patients with <z:hpo ids='HP_0001627'>cardiac abnormalities</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp> received anticoagulation therapy and <z:mp ids='MP_0005048'>thrombosis</z:mp> did not happen any more during follow-up </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Cardiac manifestations of APS are valve abnormalities (valve thickening and vegetations), <z:hpo ids='HP_0005315'>occlusive arterial disease</z:hpo> (<z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>), ventricular dysfunction and <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0001627'>Cardiac abnormalities</z:hpo> in APS are likely to be related to <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> </plain></SENT>
</text></document>